Patent · US Active

SIRT4 activities

US8546090B2 · kind B2 · utility

3Cited by
34References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 5, 2012
Grant dateOct 1, 2013
Priority date
Expiry dateOct 5, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/91142
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods of modulating insulin secretion and treating metabolic disorders by modulating the expression or activity of Sirt4 are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.